Paula Moran is a Scientific Consultant in Psychopharmacology and honorary Associate Professor at the School of Psychology, University of Nottingham, U.K. She received a PhD in Psychology from the National University of Ireland. She subsequently spent six years as a senior scientist in the pharmaceutical industry at the Marion Merrell Dow Research Institute, Strasbourg, France and was involved in a number of drug discovery projects for Alzheimer's Disease and Schizophrenia. She returned to academia to take up an EU Human Capital and Mobility Fellowship at the Institute of Psychiatry, Kings College London, U.K. Since then she has continued work at the University of Nottingham on cognitive impairment in animal models, psychiatric patients and in healthy population groups. She has authored and co-authored over 100 scientific publications. She has received several awards for her research from the British Psychological Society (BPS), International Congress on Schizophrenia Research (ICOSR), British Association for Psychopharmacology (BAP) and Collegium Internationale Neuro-Psychopharmacologicum (CINP). She has sat on the scientific advisory panel for psychotic disorders for the European College of Neuropsychopharmacology (ECNP) and served as preclinical external affairs officer of the British Association for Psychopharmacology (BAP).
4:15 PM - 5:15 PM (PDT)
Wednesday, June 15
Widespread evidence shows that cognitive problems are the second most commonly reported symptom …
9:00 AM - 10:00 AM (PDT)
Thursday, June 16
The psychedelics industry has evolved from a stigmatized counterculture phenomenon to a…